Feedlot performance of beef heifers implanted with Synovex-H: effect of melengestrol acetate, ovariectomy or active immunization against GnRH.
The effects on anabolic steroid implantation on feedlot performance and carcass composition and quality were examined in control (CNTRL), ovariectomized (OVX) or melengestrol acetate-fed (MGA) beef heifers or heifers actively immunized against GnRH (Anti-GnRH). Heifers (n = 112) were assigned randomly to a 2 x 4 factorial experiment. The two classes were made up of heifers not implanted and those implanted with Synovex-H. The four treatments were 1) CNTRL, 2) MGA, 3) OVX and 4) Anti-GnRH. Heifers were housed in individual pens and fed a high-energy diet for the 4-mo study. Synovex-H increased final live weight (P less than .005), carcass weight (P less than .005), ADG (P less than .0001) and feed efficiency (P less than .005) but did not alter carcass quality and yield grade (P greater than .05). Synovex-H increased deposition of protein (P less than .0001) and reduced deposition of fat (P less than .0001). Oral administration of MGA had no significant effect on feedlot performance or carcass quality. For heifers not implanted, active immunization against GnRH, but not ovariectomy, depressed ADG (P less than .05) and increased fat deposition (P less than .05) while reducing protein deposition (P less than .05). These effects of active immunization were reversed by concurrent administration of Synovex-H. Feedlot performance and carcass composition of heifers were improved by administration of anabolic steroids. When heifers were housed singly, neither ovariectomy, active immunization against GnRH nor oral administration of MGA improved feedlot performance of heifers implanted with Synovex-H.
Adams
T E
TE
Dept. of Anim. Sci., Univ. of California, Davis 95616.
Dunbar
J R
JR
Berry
S L
SL
Garrett
W N
WN
Famula
T R
TR
Lee
Y B
YB
D000818:Animals; D002417:Cattle / Q000254:growth & development* / Q000502:physiology; D004338:Drug Combinations; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000276:immunology*; D007114:Immunization / Q000662:veterinary; D008552:Melengestrol Acetate / Q000494:pharmacology*; D010052:Ovariectomy / Q000662:veterinary*; D011897:Random Allocation; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology*; D015430:Weight Gain / Q000187:drug effects
D004338:Drug Combinations; D004343:Drug Implants; C046521:estradiol benzoate, testosterone propionate drug combination; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D004958:Estradiol; D008552:Melengestrol Acetate